Ficha del valor · trimestre archivado
OLMA
Olema Pharmaceuticals, Inc. · Healthcare · Biotechnology
16Tenedores rastreados
0Δ titulares
15.07MAcciones mantenidas
$147.57MValor declarado
+1Nuevas posiciones
−1Cierres
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -6.9% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | -5 | 48.00M | $600.59M | +5 | −10 |
| Q1 2026 | 85 | +7 | 50.63M | $755.34M | +15 | −8 |
| Q4 2025 | 78 | +3 | 39.80M | $995.19M | +3 | — |
| Q3 2025 | 16 | 0 | 15.07M | $147.57M | +1 | −1 |
| Q2 2025 | 13 | -1 | 13.76M | $58.63M | — | −1 |
| Q1 2025 | 11 | -1 | 8.23M | $30.93M | +1 | −2 |
| Q4 2024 | 12 | 0 | 11.47M | $66.81M | — | — |
| Q3 2024 | 11 | 0 | 7.78M | $92.93M | +1 | −1 |
| Q2 2024 | 11 | — | 6.52M | $70.59M | — | — |
Quién lo tiene en cartera · Q3 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 4.73M | +2.6% | $46.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 4.73M | +2.6% | $46.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 4.73M | +2.6% | $46.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 4.73M | +2.6% | $46.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 4.73M | +2.6% | $46.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 4.73M | +2.6% | $46.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 4.73M | +2.6% | $46.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 4.73M | +2.6% | $46.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 4.73M | +2.6% | $46.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 4.73M | +2.6% | $46.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (pasivo) | 3.20M | -2.1% | $31.30M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (pasivo) | 3.20M | -2.1% | $31.30M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (pasivo) | 3.20M | -2.1% | $31.30M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 1.56M | — | $15.23M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 1.56M | — | $15.23M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 1.56M | — | $15.23M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 1.56M | — | $15.23M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 1.56M | — | $15.23M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 1.56M | — | $15.23M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Geode Capital Management ✦ (pasivo) | 1.28M | -3.8% | $12.49M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | Geode Capital Management ✦ (pasivo) | 1.28M | -3.8% | $12.49M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 1.24M | -27.6% | $12.11M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 1.24M | -27.6% | $12.11M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 24 | State Street Global Advisors ✦ (pasivo) | 1.09M | +4.0% | $10.71M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 25 | Goldman Sachs Group ✦ | 803.88K | — | $7.87M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Goldman Sachs Group ✦ | 803.88K | — | $7.87M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Millennium Management ✦ | 331.45K | -73.9% | $3.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | Point72 Asset Management ✦ | 245.42K | Nuevo | $2.40M | 0.0% | New | 1 | SEC ↗ |
| 29 | Wellington Management ✦ | 204.21K | -10.4% | $2.00M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 30 | Wellington Management ✦ | 204.21K | -10.4% | $2.00M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 31 | Wellington Management ✦ | 204.21K | -10.4% | $2.00M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 32 | Two Sigma Investments ✦ | 109.53K | +18.4% | $1.07M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 33 | Renaissance Technologies ✦ | 90.10K | +53.2% | $882,079 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 81.18K | -2.0% | $794,761 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 81.18K | -2.0% | $794,761 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 81.18K | -2.0% | $794,761 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 81.18K | -2.0% | $794,761 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 81.18K | -2.0% | $794,761 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 60.26K | — | $589,966 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 60.26K | — | $589,966 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 60.26K | — | $589,966 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 60.26K | — | $589,966 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 60.26K | — | $589,966 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 60.26K | — | $589,966 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | T. Rowe Price ✦ | 31.78K | +6.4% | $312,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 46 | Fidelity (FMR) ✦ | 29.42K | +4.2% | $288,045 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 47 | Fidelity (FMR) ✦ | 29.42K | +4.2% | $288,045 | 0.0% | ▲ Add | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Point72 Asset Management | $2.40M | 0.0% |
Posición cerrada
| Marshall Wace | $54,528 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 200.00K acciones, $10,000 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q3 2025 ·
Metodología ·
Obtener esto a través de la API